Macrophage activation syndrome, a devastating complication of some rheumatic conditions, shows pathologic similarities to a rare hereditary condition. Genetic studies imply that their similarities may be more than coincidental.
Polycystic ovary syndrome, “dermatoses of pregnancy,” systemic sclerosis, subacute cutaneous lupus erythematosus, gallbladder agenesis, sarcoidosis—a close look at medical problems seen frequently in women.
An eight-year study of more than 100 patients with giant cell arteritis reveals that for the majority of patients it is not an isolated episode. Relapses tend to occur within two years, usually as polymyalgia rheumatica or cranial symptoms.
A special six-part section on vasculitis, available for free in full text online for six months, focuses on pathogenesis, treatment strategies, and the need to reconsider mechanisms in defining the subtypes.
The FDA today announced that it is preparing to regulate laboratory tests developed and marketed within a single lab. This should lead eventually to more clarity about testing for diagnosis and treatment of rheumatic diseases.